bouncyo
2023-03-08

This has an RVPH feel to it. The BE study was FDA guided and primary endpoint was met. FDA concluded no other studies are necessary for the NDA. Filing mid 2023. 40% insider ownership, 20% tutes. All looks extremely promising. I'm definitely holding.$Unicycive Therapeutics, Inc.(UNCY)$

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • KryZ
    2023-03-13
    KryZ
    Hmm...  $Reviva Pharmaceuticals Holdings, Inc.(RVPH)$   does look good too.
  • Pag
    2023-03-15
    Pag
    👍🏻👍🏻👍🏻👍🏻👍🏻👍🏻👍🏻
  • jannn
    2023-03-15
    jannn
    [smile]
  • CloudLoo
    2023-03-15
    CloudLoo
    👍👍👍😂😂
  • Hitrun
    2023-03-15
    Hitrun
    ok
  • NANAHO
    2023-03-15
    NANAHO
    😀
Leave a comment
6
7